These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9106142)

  • 21. MR enterography with oral contrast agent composed of methylcellulose, low-dose barium sulfate, sorbitol, and lactulose: assessment of diagnostic performance, reliability, image quality, and patient tolerance.
    Evrimler S; Algin O
    Clin Imaging; 2016; 40(3):523-30. PubMed ID: 27133698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Water as a contrast medium: a re-evaluation using the multidetector-row computed tomography.
    Makarawo TP; Negussie E; Malde S; Tilak J; Gayagoy J; Watson J; Francis F; Lincoln D; Jacobs MJ
    Am Surg; 2013 Jul; 79(7):728-33. PubMed ID: 23816008
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimization of a negative oral contrast agent for magnetic resonance imaging.
    Davis MA; Mei H; Ritsema GH
    Invest Radiol; 1994 Jun; 29 Suppl 2():S120-2. PubMed ID: 7928205
    [No Abstract]   [Full Text] [Related]  

  • 24. Mangafodipir trisodium (MnDPDP)-enhanced magnetic resonance imaging of the liver and pancreas.
    Wang C
    Acta Radiol Suppl; 1998; 415():1-31. PubMed ID: 9571956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Positive bowel contrast agent for MR imaging of the abdomen: phase II and III clinical trials.
    Patten RM; Lo SK; Phillips JJ; Bowman SC; Glazer GM; Wall SD; Bova JG; Harris RD; Wheat RL; Johnson CD
    Radiology; 1993 Oct; 189(1):277-83. PubMed ID: 8372205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of nutritional support formula as a gastrointestinal contrast agent for MRI.
    Mirowitz SA; Susman N
    J Comput Assist Tomogr; 1992; 16(6):908-15. PubMed ID: 1430440
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insights of an abdominal imager: what do we need for MRI enhancement?
    Kressel HY
    Magn Reson Med; 1991 Dec; 22(2):314-8. PubMed ID: 1812363
    [No Abstract]   [Full Text] [Related]  

  • 28. Magnetic resonance imaging of the small bowel in Crohn's disease.
    Frøkjaer JB; Larsen E; Steffensen E; Nielsen AH; Drewes AM
    Scand J Gastroenterol; 2005 Jul; 40(7):832-42. PubMed ID: 16109660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Magnetic resonance tomography: value and limits in gastroenterologic diagnosis].
    Laniado M; Duda S; Claussen CD
    Bildgebung; 1992 Jun; 59(2):61-7. PubMed ID: 1511212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A potentially artifact-free oral contrast agent for gastrointestinal MRI.
    Liebig T; Stoupis C; Ros PR; Ballinger JR; Briggs RW
    Magn Reson Med; 1993 Nov; 30(5):646-9. PubMed ID: 8259066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Barium sulfate for abdominal computer assisted tomography.
    Hatfield KD; Segal SD; Tait K
    J Comput Assist Tomogr; 1980 Aug; 4(4):570. PubMed ID: 7391310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Magnesium sulfate as an oral contrast medium in magnetic resonance imaging of the small intestine.
    Shi H; Liu C; Ding HY; Li CW
    Eur J Radiol; 2012 Mar; 81(3):e370-5. PubMed ID: 22197089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contrast-enhanced magnetic resonance imaging of the abdomen.
    Brown ED; Semelka RC
    Magn Reson Q; 1994 Jun; 10(2):97-124. PubMed ID: 7986704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Oral contrast medium for magnetic resonance tomography of the abdomen. II. Phase I clinical testing of gadolinium-DTPA].
    Kornmesser W; Laniado M; Hamm B; Clauss W; Weinmann HJ; Schulz E; Wolf KJ; Felix R
    Rofo; 1987 Nov; 147(5):550-6. PubMed ID: 2825293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of low-energy CT imaging on selection of positive oral contrast media concentration.
    Patino M; Murcia DJ; Iamurri AP; Kambadakone AR; Hahn PF; Sahani DV
    Abdom Radiol (NY); 2017 May; 42(5):1298-1309. PubMed ID: 27933477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Gadolinium-DTPA as an oral contrast medium for magnetic resonance tomography of the pancreas].
    Neumann K; Kaminsky S; Gogoll M; Clauss W; Langer M; Felix R
    Rofo; 1991 Mar; 154(3):262-8. PubMed ID: 1849293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An aqueous gastrointestinal contrast agent for use in echo-planar MR imaging.
    Hahn PF; Saini S; Cohen MS; Goldberg M; Reimer P; Mueller PR
    Magn Reson Med; 1992 Jun; 25(2):380-3. PubMed ID: 1614323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Gadolinium-DTPA as an oral contrast medium for MR tomography of the abdomen].
    Krahe T; Dölken W; Lackner K; Houselog M; Habscheid W; Clauss W
    Rofo; 1990 Aug; 153(2):167-73. PubMed ID: 2168072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Oral contrast media for the magnetic resonance tomography of the abdomen. A clinical trial of the tolerance for gadolinium-DTPA].
    Kaminsky S; Laniado M; Gogoll M; Kornmesser W; Clauss W; Felix R
    Rofo; 1992 Jan; 156(1):17-23. PubMed ID: 1733470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiographic contrast study of the upper gastrointestinal tract of eight dogs using carboxymethylcellulose mixed with a low concentration of barium sulphate.
    Chang JH; Lee KC; Choi HJ; Yoon JH; Choi MC
    Vet Rec; 2004 Feb; 154(7):201-4. PubMed ID: 15002400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.